Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Malignant Melanoma

Free Subscription Articles published in Nat Med Retrieve available abstracts of 12 articles: HTML format Text format

Single Articles

January 2018
1. BOSHUIZEN J, Koopman LA, Krijgsman O, Shahrabi A, et al
   Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors.
   Nat Med. 2018 Jan 15. pii: nm.4472. doi: 10.1038/nm.4472.
   PubMed     Text format     Abstract available
   
   
   October 2017
2. MURGAI M, Ju W, Eason M, Kline J, et al
   KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis.
   Nat Med. 2017;23:1176-1190.
   PubMed     Text format     Abstract available
   
   
   August 2017
3. XUE Y, Martelotto L, Baslan T, Vides A, et al
   An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
   Nat Med. 2017;23:929-937.
   PubMed     Text format     Abstract available
   
   
   July 2017
4. MAYORCA-GUILIANI AE, Madsen CD, Cox TR, Horton ER, et al
   ISDoT: in situ decellularization of tissues for high-resolution imaging and proteomic analysis of native extracellular matrix.
   Nat Med. 2017;23:890-898.
   PubMed     Text format     Abstract available
   
   
   December 2016
5. PEINADO H, Alec kovic M, Lavotshkin S, Matei I, et al
   Corrigendum: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.
   Nat Med. 2016;22:1502.
   PubMed     Text format    
   
   
   October 2016
6. LINNEMANN C, van Buuren MM, Bies L, Verdegaal EM, et al
   Corrigendum: High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma.
   Nat Med. 2016;22:1192.
   PubMed     Text format    
   
   
   August 2016
7. SHEN CH, Kim SH, Trousil S, Frederick DT, et al
   Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma.
   Nat Med. 2016 Aug 8. doi: 10.1038/nm.4155.
   PubMed     Text format     Abstract available
   
   
   June 2016
8. LAFAVE LM, Beguelin W, Koche R, Teater M, et al
   Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status".
   Nat Med. 2016;22:578-9.
   PubMed     Text format    
   
   
   
9. SCHOUMACHER M, Le Corre S, Houy A, Mulugeta E, et al
   Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status.
   Nat Med. 2016;22:577-8.
   PubMed     Text format    
   
   
   February 2016
10. GROS A, Parkhurst MR, Tran E, Pasetto A, et al
    Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.
    Nat Med. 2016 Feb 22. doi: 10.1038/nm.4051.
    PubMed     Text format     Abstract available
    
    
    November 2015
11. GAO H, Korn JM, Ferretti S, Monahan JE, et al
    High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
    Nat Med. 2015;21:1318-25.
    PubMed     Text format     Abstract available
    
    
    June 2015
12. VIZOSO M, Ferreira HJ, Lopez-Serra P, Carmona FJ, et al
    Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR.
    Nat Med. 2015 Jun 1. doi: 10.1038/nm.3863.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: